Share

October 2021; 11 (5) Case

Ocular Flutter in Acute Doxylamine Intoxication

Diana Z. Li, Zoё R. Williams, Nicholas Nacca, Karlo J. Lizarraga
First published September 11, 2020, DOI: https://doi.org/10.1212/CPJ.0000000000000956
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
198

Share

Article Information

vol. 11 no. 5 e740-e741
DOI: 
https://doi.org/10.1212/CPJ.0000000000000956
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received May 16, 2020
  • Accepted July 7, 2020
  • First Published September 11, 2020.

Article Versions

Copyright & Usage: 
© 2021 American Academy of Neurology

Author Disclosures

    1. Diana Z. Li, MD,
    2. Zoё R. Williams, MD,
    3. Nicholas Nacca, MD and
    4. Karlo J. Lizarraga, MD, MSc
  1. Diana Z. Li, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Zoё R. Williams, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Nicholas Nacca, MD and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Karlo J. Lizarraga, MD, MSc
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Brain & Life en Español, Editorial Board, 2017-Present, no compensation. (2) Surgical Neurology International - Stereotactic, Editorial Board, 2017-Present, no compensation.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. (1) Non-profit entity: Director and founder of "La Escuelita AQMED" in Peru. This local entity provides supplementary medical education in the city of Arequipa, Peru.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Movement Disorders Fellowship Grant from the Dystonia Medical Research Foundation Canada (2018-2019).

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Neurology (DZL, ZRW, KJL), Department of Ophthalmology (ZRW), Department of Neurosurgery (ZRW), and Department of Emergency Medicine (NN), University of Rochester Medical Center; Upstate Poison Center, Syracuse; and Motor Physiology and Neuromodulation Program (KJL), Division of Movement Disorders, and Center for Health + Technology (CHeT), Department of Neurology, University of Rochester Medical Center, Rochester, NY.
  1. Correspondence
    Dr. Lizarraga karlo.lizarraga{at}gmail.com

Article usage

Article usage: September 2020 to October 2023

AbstractFullPdfSource
Sep 2020108010Highwire
Oct 20206206Highwire
Nov 20206402Highwire
Dec 20207001Highwire
Jan 20215100Highwire
Feb 20215003Highwire
Mar 20214505Highwire
Apr 20213402Highwire
May 20213301Highwire
Jun 20211605Highwire
Jul 20214200Highwire
Aug 20212801Highwire
Sep 20212600Highwire
Oct 202184224Highwire
Nov 20213252014Highwire
Dec 202113936Highwire
Jan 20224123Highwire
Feb 20225503Highwire
Mar 202264111Highwire
Apr 20224007Highwire
May 202261016Highwire
Jun 202277616Highwire
Jul 202297216Highwire
Aug 20224208Highwire
Sep 20224717Highwire
Oct 20224814Highwire
Nov 20225802Highwire
Dec 20223403Highwire
Jan 20233500Highwire
Feb 20232911Highwire
Mar 20232601Highwire
Apr 20231502Highwire
May 20231902Highwire
Jun 2023903Highwire
Jul 202338010Highwire
Aug 202319210Highwire
Sep 20232604Highwire
Oct 20233219Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me